<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396706</url>
  </required_header>
  <id_info>
    <org_study_id>EA-14-01-077</org_study_id>
    <nct_id>NCT02396706</nct_id>
  </id_info>
  <brief_title>RCT to Evaluate the Efficacy and Safety of Ivy Leaves Cough Liquid vs. Placebo in the Treatment of Acute Cough</brief_title>
  <official_title>Randomized, Controlled, Double-blind, Multi-center Trial to Evaluate the Efficacy and Safety of a Liquid Containing Ivy Leaves Dry Extract vs. Placebo in the Treatment of Acute Cough</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Engelhard Arzneimittel GmbH &amp; Co.KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Engelhard Arzneimittel GmbH &amp; Co.KG</source>
  <brief_summary>
    <textblock>
      Randomized, controlled, double-blind, multi-center trial to evaluate the efficacy and safety
      of a liquid containing ivy leaves dry extract vs. placebo in the treatment of acute cough
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS)</measure>
    <time_frame>whole treatment period over 7 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">181</enrollment>
  <condition>Acute Cough</condition>
  <arm_group>
    <arm_group_label>Ivy Leaves Cough Liquid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ivy Leaves Cough Liquid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ivy Leaves Cough Liquid</intervention_name>
    <arm_group_label>Ivy Leaves Cough Liquid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Acute cough with symptoms lasting 2-3 days prior to treatment

          2. Men or women of any ethnic origin

          3. Age 18 to 75 years

          4. Subjects who are able to understand and are willing to comply to trial instructions

          5. Having given written informed consent

          6. Satisfactory health except for the cough as determined by the investigator based on
             medical history and physical examination

          7. CS score of at least 50 mm on a 100 mm VAS at V1

          8. Acute BSS of at least 10 points at V1

          9. VCD score of at least 2 points at V1

        Exclusion Criteria:

          1. Allergic bronchial asthma, bronchial hyperreactivity, chronic bronchitis, other
             chronic or inherited lung disease

          2. History of hypersensitivity to any excipient of the applied drugs

          3. History of drug hypersensitivity, asthma, urticaria, or other severe allergic
             diathesis as well as current hay fever

          4. History of chronic gastritis or peptic ulcers

          5. Any gastrointestinal complaints within 7 days before V1

          6. Participation in a clinical trial within 30 days prior to the treatment phase of this
             study or concomitantly

          7. Treatment with corticoids, beta-2 agonists (e.g. salbutamol, fenoterol), expectorants,
             theophylline, antitussives, anaesthetics, acetylsalicylic acid (e.g. aspirin) or other
             non-steroidal anti-inflammatory drugs, leukotriene inhibitors, angiotensin-converting
             enzyme (ACE) inhibitors, antiviral drugs or antibiotics, antihistamines,
             immunosuppressants, isoprenaline, atropine, sodium cromoglycate or homeopathic drugs
             against common cold within 7 days before V1

          8. Drug or alcohol abuse in the opinion of the investigator

          9. Pregnant or nursing (lactating) women

         10. Women of child-bearing potential (defined as all women physiologically capable of
             becoming pregnant) who are not using an acceptable method of contraception.

         11. Subjects with significant diseases, defined as a disease which, in the opinion of the
             investigator, may either put the subject at risk because of participation in the trial
             or a disease which may influence the results of the trial or the subject's ability to
             participate in the trial; includes subjects with a history of gastrointestinal
             bleeding, significant cardiovascular, liver or renal disease.

         12. Subjects directly or indirectly involved in the execution of this protocol, including
             employees of the CRO and persons related to them.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Schaefer</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medizentrum Essen-Borbeck</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizentrum Essen-Borbeck</name>
      <address>
        <city>Essen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>September 2, 2015</last_update_submitted>
  <last_update_submitted_qc>September 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

